Multidrug resistance and malignancy in human osteosarcoma

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2434-2439

  Scotlandi, Katia ^a   Serra, Massimo ^a   Nicoletti, Giordano ^b   Vaccari, Monica ^b   Manara, Maria Cristina ^a   Nini, Giuseppe ^a   Landuzzi, Lorena ^b   Colacci, Annamaria ^b   Bacci, Gaetano ^a   Bertoni, Franco ^a   Picci, Piero ^a   Campanacci, Mario ^a   Baldini, Nicola ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b Istituto di Cancerologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GLYCOPROTEIN P;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; OSTEOSARCOMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

EID: 9344255443     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Chen, C., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., and Roninson, I. B. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug resistant human cells Cell, 47: 381-389, 1986
2. Gottesman, M. M , and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev. Biochem., 62. 385-427, 1993.
3. Bradley, G , Juranka, P. F., and Ling, V. Mechanisms of multidrug resistance. Biochim. Biophys. Acta, 948: 87-128, 1988.
4. Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S-L., Gazdar, A., Pirker, R., Green, A , Crist, W., Brodeur, G. M., Lieber, M., Cossman, J , Gottesman, M. M., and Pastan, I Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst., 81: 116-124, 1989.
5. Yuen, A. R , and Sikic, B. I. Multidrug resistance in lymphomas. J. Clin. Oncol., 12: 2453-2459, 1994.
6. Chan, H. S. L., DeBoer, G., Thorner, P. S., Haddad, G., Gallie, B. L., and Ling, V. Multidrug resistance. Clinical opportunities in diagnosis and circumvention. Hematol. Oncol. Clin. N. Am., 8: 383-410, 1994
7. Salmon, S E., Grogan, T. M , Miller, T. P., and Dalton, W. S. Multidrug resistance Relevance to adjuvant therapy? In: S. E. Salmon (ed.), Adjuvant Therapy of Cancer VI. pp 26-32 Philadelphia: W. B. Saunders Company, 1990.
8. Bradley, G., and Ling, V. P-glycoprotein, multidrug resistance and tumor progression Cancer Metastasis Rev., 13. 223-233, 1994.
9. Goasguen, J. E , Dossot, J-M., Fardel O., Le Mee, F., Le Gall, E. Leblay, R., Le Prise, P Y , Chaperon, J., and Fauchet, R. Expression of the multidrug-resistance associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood, 81: 2394-2398, 1993.
10. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J , Treille, D , and Fiere, D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood, 79: 473-476, 1992.
11. Chan, H. S. L., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N , Yeger, H , and Ling, V P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl J. Med., 325. 1608-1614, 1991
12. Gerlach, J H., Bell, D. R , Karakousis, C., Slocum, H K., Kartner, N., Rustum, Y. M , Ling, V , and Baker, R M. P-glycoprotein in human sarcoma: evidence for multidrug resistance. J. Clin. Oncol., 5: 1452-1460, 1987.
13. Tawa, A., Inoue, M., Ishihara, S., Hara, J , Yumura-Yagi, K., Okumura, K., Okada, A., Nihei, A , Tasuchi, J., Kanai, N , Tsuruo, T., and Kawa-Ha, K Increased expression of the multidrug-resistance gene in undifferentiated sarcoma. Cancer (Phila.), 66. 1980-1983, 1990.
14. Vergier, B., Cany, L., Bonnet, F., Robert, J., de Mascarel, A., and Coindre, J. M Expression of MDR1/P-glycoprotein in human sarcomas. Br. J. Cancer, 68 1221-1226, 1993.
15. Chan, H. S. L , Thorner, P. S , Haddad, G., and Ling, V Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood J. Clin Oncol., 8: 689-704, 1990.
16. Stein U., Wunderlich, V., Haensch, W , and Schmidt-Peter, P. Expression of the mdr1 gene in bone and soft tissue sarcomas of adult patients. Eur. J. Cancer, 29A: 1979-1981, 1993
17. Wunder, J S., Bell, R S., Wold, L , and Andrulis, I. L Expression of the multidrug resistance gene in osteosarcoma: a pilot study. J. Orthop. Res., 11: 396-403, 1993
18. Serra, M., Scotlandi, K., Manara, M. C., Maurici, D., Benini, S , Sarti, M., Campanacci, M., and Baldini, N. Analysis of P-glycoprotein expression in osteosarcoma. Eur. J. Cancer, 31A: 1998-2002, 1995
19. Baldini, N., Scotlandi, K., Barbanti-Brodano, G., Manara, M. C., Maurici, D., Bacci, G., Bertoni, F., Picci, P., Sottili, S., Campanacci, M., and Serra, M. P-glycoprotein expression and outcome in high-grade osteosarcoma. N. Engl J Med., 333: 1380-1385, 1995
20. Weinstein, R. S., Jakate, S. M., Dominguez, J M , Lebovitz, M. D., Koukoulis, G. K., Kuszak, J. R., Klusens, L. F., Grogan, T. M , Saclarides, T. J., Roninson, I. B., and Coon, J. S. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis Cancer Res., 51. 2720-2726, 1991
21. Biedler, J. L., and Spengler, B. A. Reverse transformation of multidrug-resistant cells. Cancer Metastasis Rev., 13: 191-207, 1994.
22. Bashir, I., Sikora, K., Abel, P., and Foster, C. S. Establishment and in vivo characterization of multidrug-resistant Dunning R3327 rat prostate-carcinoma cell-lines. Int. J. Cancer, 57: 719-726, 1994
23. Serra, M., Scotlandi K., Manara, M. C., Maurici, D., Lollini, P-L , De Giovanni, C., Toffoli, G , and Baldini, N. Establishment and characterization of multidrug-resistant human osteosarcoma cell lines. Anticancer Res , 13: 323-330, 1993.
24. Colacci, A , Albini, A., Melchiori, A , Nanni, P., Nicoletti, G., Noonan, D., Parodi, S., and Grilli, S. Induction of a malignant phenotype in BALB/c 3T3 cells by 1,1,2,2-tetrachloroethane. Int. J Oncol , 2: 937-945, 1993.
25. Albini, A., Iwamoto, Y., Kleinman, H. K , Martin, G. R., Aaronson, S. A., Koziowski, J. M., and McEwan, R. N A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
26. b gene transfection on the metastatic ability of B16 melanoma cells. Int J. Cancer, 48: 270-276, 1991.
27. Bacci, G., Picci, P., Ferrari, S., Ruggieri, P., Casadei, R., Tienghi, A , Brach del Prever, A , Gherlinzoni, F., Mercuri, M., and Monti, C. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer (Phila.), 72: 3227-3238, 1993
28. Zelterman, D., and Louis, T. A. Contingency tables in medical studies. In: J. C. Bailar and F. Mosteller (eds.), Medical Uses of Statistics, pp. 293-310. Waltham, MA: New England Journal of Medicine Books, 1992.
29. Stein, G. S , Lian, J. B., and Owen, T A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J., 4: 3111-3123, 1990.
30. Biedler, J L., Riehm, H., Peterson, R. H. F., and Spengler, B. A. Membrane-mediated drug resistance and phenotypic reversion to normal growth behavior of Chinese hamster cells. J. Natl. Cancer Inst., 55: 671-680, 1975
31. Bénard, J., Da Silva, J , Teyssier, J-R., and Riou, G. Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line Int J Cancer, 43: 471-477, 1989.
32. Link, M P., Goorin, A. M., Miser, A. W , Green, A A., Pratt, C. B , Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J A., Ayala, A G., Shuster, J. J., Abelson, H. T , Simone, J. V., and Vietti, T J. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity N. Engl. J. Med., 314: 1600-1606, 1986.
33. Simone, J. V., Meyer, W. H., and Link, M. P. Osteosarcoma Good news despite crude tools. J. Clin. Oncol., 10: 1-2, 1992.
34. Ruoslahti, E., and Giancotti, F. G. Integrins and tumor cells dissemination Cancer Cells, 1: 119-126, 1989.
35. McClean, S., and Hill, B. T An overview of membrane, cytosolic and nuclear proteins associated with the expression of resistance to multiple drugs in vitro. Biochem. Biophys Acta, 1114: 107-127, 1992.
36. Jaffe, N., Smith, E , Abelson, H. T., and Frei, E., III Osteogenic sarcoma, alterations in the pattern of pulmonary metastases with adjuvant chemotherapy. J Clin Oncol., 1: 251-254, 1983.
37. Goorin, A. M., Shuster, J. J , Baker, A , Horowitz, M. E., Meyer, W. H., and Link, M. P. Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. J. Clin. Oncol., 9: 600-605, 1991.
38. Blaney, S. M., Smith, M. A., and Grem, J. L. Doxorubicin. Role in the treatment of osteosarcoma. In: G. Bennet Humphrey, H. Schraffordt Koops, W. M. Molenaar, and A. Postman (eds), Osteosarcoma in Adolescents and Young Adults, pp. 55-73 Boston: Kluwer, 1993.
39. Bahir, I., Sikora, K , and Foster, C. S. Multidrug resistance and behavioural phenotype of cancer cells. Cell Biol. Int., 17. 907-917, 1993.